NanoViricides
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NanoViricides and other ETFs, options, and stocks.About NNVC
NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs.
CEOAnil R. Diwan
CEOAnil R. Diwan
Employees7
Employees7
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2005
Founded2005
Employees7
Employees7
NNVC Key Statistics
Market cap26.85M
Market cap26.85M
Price-Earnings ratio-2.52
Price-Earnings ratio-2.52
Dividend yield—
Dividend yield—
Average volume287.55K
Average volume287.55K
High today$1.30
High today$1.30
Low today$1.24
Low today$1.24
Open price$1.25
Open price$1.25
Volume74.88K
Volume74.88K
52 Week high$2.23
52 Week high$2.23
52 Week low$0.94
52 Week low$0.94
Stock Snapshot
As of today, NanoViricides(NNVC) shares are valued at $1.25. The company's market cap stands at 26.85M, with a P/E ratio of -2.52.
On 2026-01-07, NanoViricides(NNVC) stock moved within a range of $1.24 to $1.30. With shares now at $1.25, the stock is trading +0.8% above its intraday low and -4.2% below the session's peak.
Trading activity shows a volume of 74.88K, compared to an average daily volume of 287.55K.
Over the past 52 weeks, NanoViricides(NNVC) stock has traded between a high of $2.23 and a low of $0.94.
Over the past 52 weeks, NanoViricides(NNVC) stock has traded between a high of $2.23 and a low of $0.94.
People also own
Based on the portfolios of people who own NNVC. This list is generated using Robinhood data, and it’s not a recommendation.